Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132580) titled 'Preliminary Study on [18F]SSY-P001 PET Imaging of Cerebral Neuroinflammation in Patients with Cerebral Amyloid Angiopathy' on Sept. 15.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Huashan Hospital, Fudan University

Condition: cerebral amyloid angiopathy(CAA)

Intervention: Healthy ontrol group:Intravenous injection of [1?F]SSY-P001 imaging agent (approximately 300 MBq, about 8.1 mCi).

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-15

Target Sample Size: Healthy ontrol group:3;cerebral amyloid angiopathy group:6;

Countries ...